DEMENTIA/ALZHEIMER

The positive topline results from Study 201 have led to the initiation of an open-label extension for the subjects previously enrolled in Study 201, which is set to begin later this year.

About NeurologyLive's Dementia & Alzheimer Clinical Focus page:

NeurologyLive Dementia & Alzheimer Disease Clinical Focus page serves as a resource for clinical news, articles, videos, and newly released data pertaining to both dementia and Alzheimer disease. Coverage found here includes updates from the floor of conferences and annual meetings attended by the world’s most respected key neurology thought leaders, as well as video interviews with leading experts in these neurological disorders.

This page features breaking news coverage of approvals from the U.S. Food and Drug Administration (FDA), key takeaways from the new and emerging therapies being evaluated in clinical trials, and notifications of updates to clinical guidelines. The Dementia & Alzheimer Clinical Focus page provides relevant, high-quality resources for practicing neurologists, to help improve patient care.